Sign in

or Register now

ProstateCommons.com

See all of our health sites at www.HealthCentral.com
Sunday, October, 25, 2009

Tarceva

Celebrex+Tarceva triples response rates in lung cancer patients, study finds

October 02, 2008
Adding Celebrex to the current lung cancer treatment Tarceva increased response rates in patients by 33 percent in a new study at the University of California. Researchers suggest that the addition of Celebrex to Tarceva may help patients overcome their resistance to Tarceva and thus help inhibit their tumors' growth. Read more »

Expert & Community Posts

87_4803
What is Personalized Medicine for Breast Cancer?
By Kevin Knopf, MD , Health Expert

Personalized medicine actually has two meanings. The first, and probably the one most familiar to... Read more »

Health Guide

Brain Tumors: Primary: Highlights
...tumors will respond to epidermal growth factor receptor (EGFR) kinase inhibitors such as erlotinib (Tarceva) and gefitinib (Iressa), suggests a New England Journal of Medicine study.Radiotherapy... Read more »
Non-Small Cell Lung Cancer: Highlights
...talking to your doctor.Results from an ongoing study show that adding bevacizumab (Avastin) to erlotinib (Tarceva) or to chemotherapy increases disease-free survival time. The study looked at... Read more »
Non-Small Cell Lung Cancer: Investigative Agents
...disease-free survival time in patients with advanced NSCLC is longer when adding bevacizumab to erlotinib (Tarceva) or to chemotherapy.Antisense OligonucleotideAntisense oligonucleotides are drugs... Read more »
Non-Small Cell Lung Cancer: Chemotherapy Treatments
...you are currently taking gefitinib, do not stop taking it without talking to your doctor.Erlotinib (Tarceva) is in the same medication class as gefitinib, but it shows very promising results in... Read more »
Brain Tumors: Primary: Diagnosis
...patients may respond to epidermal growth factor receptor (EGFR) kinase inhibitors, such as erlotinib (Tarceva) and gefitinib (Iressa).A genetic profile can also help give doctors a better idea of... Read more »

Related News

Tarceva extends life of patients with pancreatic cancer
October 02, 2008

According to a new study, the cancer medication Tarceva may improve the chance of survival in patients with advanced pancreatic cancer. The results,... Read summary »

Device Tracks Progress of Lung Cancer
July 11, 2008

By Kirsten Houmann, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- Better treatment may be on the horizon for lung cancer... Read summary »